A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia

Erythropoiesis-stimulating agents improve the NYHA functional class and decrease the hospital readmission rates for heart failure; however, little is known about the influence of continuous erythropoietin receptor activator (CERA) on the heart. Therefore, a prospective study was conducted to investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sezai, Akira, Sekino, Hisakuni, Taoka, Makoto, Osaka, Shunji, Tanaka, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046271/
https://www.ncbi.nlm.nih.gov/pubmed/36979925
http://dx.doi.org/10.3390/biomedicines11030946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046271/
https://www.ncbi.nlm.nih.gov/pubmed/36979925
http://dx.doi.org/10.3390/biomedicines11030946

Ejemplares similares